Mind Medicine Stock Net Income
Mind Medicine fundamentals help investors to digest information that contributes to Mind Medicine's financial success or failures. It also enables traders to predict the movement of Mind OTC Stock. The fundamental analysis module provides a way to measure Mind Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mind Medicine otc stock.
Mind |
Mind Medicine OTC Stock Net Income Analysis
Mind Medicine's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Mind Medicine Net Income | (35.34 M) |
Most of Mind Medicine's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mind Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Mind Medicine reported net income of (35.34 Million). This is 110.36% lower than that of the Healthcare sector and 150.45% lower than that of the Biotechnology industry. The net income for all United States stocks is 106.19% higher than that of the company.
Mind Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mind Medicine's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Mind Medicine could also be used in its relative valuation, which is a method of valuing Mind Medicine by comparing valuation metrics of similar companies.Mind Medicine is currently under evaluation in net income category among related companies.
Mind Fundamentals
| Return On Equity | -75.78 | |||
| Return On Asset | -41.54 | |||
| Current Valuation | 999.44 M | |||
| Shares Outstanding | 326.13 M | |||
| Shares Owned By Insiders | 0.49 % | |||
| Shares Owned By Institutions | 0.46 % | |||
| EBITDA | (31.89 M) | |||
| Net Income | (35.34 M) | |||
| Cash And Equivalents | 80.09 M | |||
| Cash Per Share | 0.26 X | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 34.06 X | |||
| Cash Flow From Operations | (24.18 M) | |||
| Number Of Employees | 22 | |||
| Market Capitalization | 705.87 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Mind Medicine information on this page should be used as a complementary analysis to other Mind Medicine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Mind OTC Stock
If you are still planning to invest in Mind Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mind Medicine's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |